MedPage Today on MSN
Regulatory T-Cell Drug Promising for Eczema, With Hint for Asthma as Well
For the primary endpoint, Eczema Area and Severity Index (EASI) improved by 53-61% in a dose-dependent manner across the ...
No one should have to suffer from the dry, flaky skin and blisters that are the most common symptoms of eczema, researchers at the Johns Hopkins School of Medicine want Marylanders to know. “Eczema is ...
A "groundbreaking" new technology from Heriot-Watt University in Edinburgh, poised to "revolutionise" eczema diagnosis and treatment, has secured over £475,000 for clinical research. The university ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback